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THE EFFECT OF CALORIE RESTRICTION ON AGE-RELATED WHITE 
MATTER DEGENERATION IN RHESUS MONKEYS 
 
 
YOM ALEMANTE 
 
ABSTRACT 
 Calorie restriction (CR) is one of the few treatments that has been 
observed to significantly extend life in a wide variety of species. While its life-
extending properties are still being investigated in primates, there is general 
agreement that it reduces oxidative stress and inflammation. Interestingly, there 
is some evidence that it may ameliorate or delay the onset of a number of 
neurodegenerative diseases, including age-related white matter degeneration. 
The processes underlying its neuroprotective effects in non-human primates are 
unknown, but oxidative stress and inflammation are potential contributors to age-
related white matter pathologies that characterize aging in the monkey brain and 
correlate with cognitive decline. To determine if CR reduces damage due to 
oxidative stress and inflammation in the monkey brain, brains from four calorie 
restricted monkeys and four matched controls brains were processed for 
immunohistochemical analysis using an antibody against the pro-inflammatory 
protein S100b. S100b is a widely expressed calcium-binding cytoplasmic protein 
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associated with neurological insults like ischemia, atrophy, and neurofibrillary 
tangles and plaques in Alzheimer’s disease. It is primarily expressed in 
astrocytes, but is also expressed to a lesser extent in microglia, 
oligodendrocytes, and some neuronal populations. Stereology was used to 
estimate density of S100b labeling in the cingulum, corpus callosum and visual 
cortex. No significant difference between calorie restricted animals and controls 
was found. More specific markers of oxidative stress and inflammation may be 
more effective in revealing any significant differences between CR and control 
brains. Potential alternatives include antibodies against 4-hydroxynonenal, a lipid 
peroxidation product, and encephalitogenic peptides of myelin basic protein, 
which are only exposed to the extracellular environment when myelin is 
damaged. 
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INTRODUCTION 
 
The aging brain has been studied and pondered for millennia. Dementia 
was first described as an illness by the ancient Egyptian Vizier Ptah-Hotep in the 
25th century BC, and the ancient Greeks studied the subject extensively 
(Sweeney, 2004). However, it wasn't until the advances of medical technology in 
the 19th century that aging diseases of the brain began to be well-characterized 
and understood. Plaques, neurofibrillary tangles and atrophy were among the 
first observable signs of the aging brain in death. Alzheimer's, Lewy-body 
dementia, and other neurodegenerative diseases were widely seen as the major 
symptoms of age-related cognitive decline (Berchtold and Cotman, 1998). 
However, it has since been established that neuronal loss does not occur due to 
normal aging. More recent evidence suggests that most mild cognitive 
impairment (MCI) due to aging is reflective of changes in the white matter (Peters 
et al., 1998; Peters, 2002). According to this theory of aging, myelin pathologies 
accumulate over time, impairing neuronal signaling and thereby leading to 
observable cognitive impairment. The source of these observed myelin 
pathologies are still under investigation, however, oxidative stress and 
inflammation are suspected to be the primary culprits (Sohal and Weindruch, 
1996; Joseph et al., 2005). Although a plethora of treatments have been 
investigated as possible anti-aging treatments since time immemorial with limited 
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success, one of the oldest life-extending treatments remains one of the most 
effective: calorie restriction.  
Clive McCay first described the effects of calorie-restricted diets on 
lifespan in 1934 in his seminal study on rats (McCay et al., 1934, 1935). Rats 
who were fed a restricted diet were observed to live approximately twice as long 
as those allowed to eat ad libitum. Further studies in a wide variety of species, 
including yeast, drosophila, dogs, mice, and other mammals offered similar 
findings, providing strong evidence for the prospect of CR as a life extender 
(Heilbronn and Ravussin, 2003; McDonald and Ramsey, 2010). CR animals were 
superior to control animals in a number of markers other than lifespan. They tend 
not to suffer from sarcopenia and a number of diseases whose prevalence 
increases with age (Colman et al., 2008, 2009). Calorie restriction has been 
shown to attenuate the effects of aging on the brain as well. Studies using mouse 
models of Alzheimer's disease have revealed less amyloid in CR animals than 
control, as well as reduced memory deficits (Gräff et al., 2013) 
The prospect of translating findings in small CR mammals into human 
beings is a daunting one, and it wasn't until the 1980s that comprehensive CR 
studies in non-human primates began at the Wisconsin National Primate 
Research Center (WNPRC) in 1989 and the National Institute of Aging (NIA) in 
1987. While data is still being released from these studies, studies using WNPRC 
data has suggested a clear improvement in mortality rates in CR animals, as well 
as reduced brain atrophy (Colman et al., 2009). Moreover, MRI data has 
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suggested a beneficial effect of CR in protecting against age-related white matter 
tract degeneration, as represented by higher fractional anisotropy (FA) values in 
select brain regions. However, data from the NIA has not demonstrated 
significant differences in mortality over control animals, and differences in the 
diets in the two studies may explain the impact of CR, with the WNPRC effects 
possibly attributed to less consumption of an unhealthy diet (Mattison et al., 
2012). 
Despite its relative success as promoting successful aging and extending 
lifespans, calorie restriction is a drastic and rather unpalatable measure in 
combating aging. If the beneficial effects of CR are to be implemented in future 
medicine, the underlying mechanisms of its salutary effects must be uncovered. 
Given the restricted caloric intake, many have proposed that the lower metabolic 
rate of CR animals exposes their bodies to less oxidative stress and therefore 
less damage accumulated over a lifespan (Sohal and Weindruch, 1996). 
Inflammation is also thought to play a central role. Not only does inflammation 
increase with age in humans and a number of animal model, but it is also 
positively correlated with functional deficits (Chung et al., 2002; Joseph et al., 
2005; Arfanakis et al. 2013). If CR animals suffer less cellular damage, it follows 
that less inflammation would be required to repair any insults, thereby lowering 
the risk of damage from excess inflammation (Ungvari et al., 2008). Indeed, CR 
has been observed to reduce levels of inflammatory mediators and markers in 
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the body in a variety of animal models, as well as humans (Fontana et al., 2006; 
Wang et al., 2013) 
In order to uncover mechanisms of action, it is necessary to investigate 
the effects of CR on inflammatory and oxidative stress markers. One such 
marker, the protein S100b, is used as a marker of neurological insult and 
inflammation. S100b is a common protein, comprising 0.5% of all cytoplasmic 
proteins in the brain (Shapiro et al., 2010). It is primarily expressed by astrocytes, 
which secrete S100b as a neurotrophic factor at nanomolar concentrations or 
inflammatory mediator at micromolar concentrations (Sorci et al., 2010). 
However, S100b is also expressed by microglia, oligodendrocytes, some 
neuronal cells, as well as some non-CNS cells, such as adipocytes and 
cardiomyocytes in (Shapiro et al., 2010; Sorci et al., 2010). S100b has been 
shown to increase in the serum with age, and is furthermore a potential marker of 
brain injury (Portela et al., 2002). Serum levels of S100b are elevated following 
neurological insult, whether it be due to hemorrhage, ischemia, or even seizure 
(Gerlach et al., 2006). Moreover, immunohistochemistry reveals increases in 
intracellular S100b expression in peri-infarct areas following ischemia, as well as 
correlating with atrophy, plaque, and neurofibrillary tangle formation in 
Alzheimer's disease (Mori, Asano, and Town, 2010). In mouse models, over-
expression of S100b exacerbates brain damage due to ischemia (Mori et al., 
2009). Therefore, while S100b is an important inflammatory mediator, it is 
evident that over-expression can be detrimental and indicative of significant 
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neurological damage in its own right. By evaluating differences in S100b 
expression between CR and control brains, we hope to uncover any anti-
inflammatory and protective effects that CR may have on the aging brain. 
 
LITERATURE REVIEW 
 
McCay first described CR as a life-extending treatment in a study testing 
the hypothesis that retarding the onset of maturity could extend lifespans. 
Indeed, rats fed a CR diet were observed to live about 50% longer on average 
(McCay et al., 1935). Further studies soon followed in a number of animal 
models, including nematodes, fruit flies, guinea pigs, mice, cows, and dogs 
(Hursting et al., 2003). Even protozoa were observed to live longer when 
subjected to CR (Rudzinka et al., 1951). Its effectiveness in a wide variety of 
species, using diverse feeding diets, strategies, and levels of restriction strongly 
implies that whatever mechanisms underly the life-prolonging effects of calorie 
restriction are evolutionarily conserved. In fact, despite the advances in science 
over the last century, calorie restriction remains the most effective lifespan 
extender (Hursting et al., 2003, Roth, Ingram, and Lane, 2001). 
In addition to extending lifespans, calorie restriction exerts a multitude of 
positive and neutral effects on rhesus physiology (Roth, Ingram, and Lane 2001). 
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FIGURE 1 
 
 
List of physiological changes in rat and primate models of calorie restriction. 
Figure taken from Roth, Ingram, and Lane (2001). 
A number of different processes have been suggested as mediating these 
multitudinous effects. For one, decreased rates of obesity may explain some of 
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the effectiveness of CR in reducing the incidence of some age-related diseases 
(Hursting et al., 2003). Obesity seems to have neurological effects as well. It has 
been identified as a risk factor for dementia and is positively correlated with white 
matter hyperintensities and reduced hippocampal volumes, two radiological 
markers of pathological aging (Maalouf, Rho, and Mattson, 2009). However, CR 
animals have also shown health improvements over animals fed a controlled 
amount of food (Guarente and Koubova, 2003). So, while there are beneficial 
effects from the lack of obesity in CR animals, it is but a small part in explaining a 
regimen with mechanisms as wide-ranging as its effects.  
Recently, molecular approaches have been taken to uncover the 
mechanisms of CR's effects. Studies in yeast have shown that CR may regulate 
sirtuins. Yeast overexpressing the protein SIR2, a NAD+-dependent histone 
deacetylase, lived 30% longer than controls, while SIR2 negative mutants had 
drastically shorter lifespans. Calorie restriction also extended yeast lifespans by 
about 30%, however they had no effect in dysfunctional SIR2 mutants or strains 
with dysfunctional NAD synthesis (Koubova and Guarente, 2003). As a histone 
deacetylase, SIR2 is capable of impacting the function of a wide variety of genes 
and cell processes epigenetically (Li et al., 2011). 
Moreover, the rate of DNA repair, which also declines with age, is not 
impeded in animals on a CR diet, and the rate of damaged protein turnover is 
also enhanced (Masoro, 2000). Insufficient protein turnover has been suggested 
as a major contributor to age-related dysfunction, and oxidatively damaged 
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proteins are seen to accumulate in aged animals, with a concurrent fall in protein 
turnover rates. CR's enhancement of protein removal and replacement could be 
due to the depleted fat stores in CR animals. As fat stores are exhausted, protein 
degradation for energy may be activated, upregulating the rate of turnover 
(Guarente and Koubova, 2003). 
DNA replication and cell proliferation are also significantly attenuated by 
calorie restriction in a wide variety of tissues. This slower rate of replication could 
be the reason for some of its observed effects. While longer-lived cells are more 
susceptible to DNA damage, lower rates of replication could decrease the 
likelihood of copying errors, and slower proliferation could impede 
carcinogenesis. This effect would be compounded by the pro-apoptotic effects 
observed in CR animals (Hursting et al., 2003). 
The antiproliferative and pro-apoptotic effects of CR may be mediated by 
insulin-like growth factor 1 (IGF-1). IGF-1 is a central growth factor regulating 
growth, development, and apoptosis. CR mammals have universally shown 
significantly lower IGF-1 serum levels as compared to controls (Hursting et al., 
2003; Roth, Ingram, and Lane 2001). The fall in IGF-1 levels make sense 
intuitively. A drastic reduction in calorie intake should affect the balance of growth 
hormones, and would be expected to result in a shift away from growth and 
reproduction to maintenance. Under this interpretation, CR would have an 
obvious evolutionary benefit by promoting in lean times the survival of those 
animals whose energy and resources were shifted appropriately from 
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reproduction to simple maintenance and survival (Ingram et al., 2006; Guarente 
and Koubova, 2003). Indeed, in C. elegans, a severe enough caloric restriction 
causes a conversion to its dauer state, in which a kind of stasis is achieved and 
reproduction and development are stopped. In this state, not only is the organism 
more stress resistant, but lifespan is also extended greatly over its adult form 
(Ingram et al., 2006). Among the key genes regulating this transformation is daf-
2, which encodes the IGF-1 receptor in roundworms, while other key genes in the 
pathway are also analogous to other elements of the IGF-1 pathway in mammals 
(Ingram et al., 2006; Kenyon, 2011). 
Moreover, CR enhances insulin sensitivity and decreases both fasting 
blood glucose and insulin levels (Roth, Ingram, and Lane, 2001). A decrease in 
caloric intake intuitively should lead to lower blood glucose levels. Additionally, 
the low calorie consumption leads to shift to using more ketone bodies as fuel 
(Guarente and Koubova, 2003). The fall in glucose levels, insulin, and IGF-1 and 
shift from a growth profile to a maintenance one seem to be among CR’s most 
significant effects (Ingram et al., 2006; Guarente and Koubova, 2003). 
In addition to regulating growth, enhanced insulin sensitivity and lower 
blood glucose levels could result in fewer advanced-glycated end products 
(AGE), which has been observed in multiple studies of CR animals. These pro-
inflammatory glycated proteins are involved in age-related pathologies and tend 
to increase with the age of the animal (Guarente and Koubova, 2003; Shapiro et 
al., 2010). The reduction of glycated end products could therefore be a significant 
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component of calorie restriction's neuroprotective effects by reducing 
inflammatory damage.  
 
Oxidative stress and inflammation 
  
While calorie restriction has been seen to reduce oxidation such as lipid 
peroxidation, oxidized proteins, and oxidative DNA damage, the mechanisms 
behind this effect are still being uncovered (Masoro, 2000; Guarente and 
Koubova, 2003; Heilbronn and Ravussin, 2003). An early theory attributes its 
effects directly to the reduced caloric intake. The intrinsic decrease in metabolism 
from consuming fewer calories would inherently reduce the amount of reactive 
oxidative species (ROS) produced simply due to less glucose oxidation. 
Diminished calorie intake should imply a lower metabolism. Therefore, if less 
glucose is oxidized into carbon dioxide and water, it follows that there would be 
less oxidation and oxidative stresses on a calorie restricted animal's cells. 
However, there is conflicting data on this subject (Guarente and Koubova, 2003). 
While CR animals do experience a fall in metabolism once put on a restricted 
diet, rodent data shows metabolic rates stabilize over the long-run to become 
equivalent to controls for a given weight (Guarente and Koubova, 2003; Lane, 
Ingram, and Roth, 1999).  Moreover, the positive anti-aging effects of calorie 
restriction are still seen in mice and rats without an associated fall in the 
metabolic rate (Masoro, 2000). On the other hand, data in humans and rhesus 
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monkeys have shown decreases in basal metabolic rates over the long run. It's 
possible that the discrepancy derives from inaccurate measurements of resting 
metabolism in rodents, or from inherent differences between rodent and primate 
metabolism (Heilbronn and Ravussin, 2003). In any case, while the effects of CR 
on long-run basal metabolism has not been determined, its effect of preventing or 
delaying oxidative damage is well established (Masoro, 2000; Guarente and 
Koubova, 2003; Heilbronn and Ravussin, 2003). 
Reduction of oxidative damage can be accomplished a number of ways: 
by decreasing the rate of ROS production, by enhancing antioxidant defenses 
that scavenge ROS, or by promoting protein and lipid turnover and repair 
(Heilbronn and Ravussin, 2003). The overexpression of antioxidant enzymes like 
superoxide dismutase (SOD) has been demonstrated to extend lifespan in some 
species, and could be a mechanism by which CR exerts its antioxidant effects 
(Hursting et al., 2003; Heilbronn and Ravussin, 2003). SOD and other 
intracellular antioxidants (eg. catalase and glutathione peroxidase) that tend to 
decline with age remain constant or even increase under CR conditions (Hursting 
et al., 2003). 
Reactive oxidative species are primarily produced in the mitochondria, 
especially at complex I in neuronal mitochondria (Maalouf, Rho, and Mattson, 
2009). Approximately 2-5% of all Oxygen molecules respired are in fact diverted 
for ROS production, so if metabolic rate does indeed fall, ROS production should 
too (Heilbronn and Ravussin, 2003). A decrease in hydrogen peroxide (and 
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therefore likely total ROS) production at complex I has been demonstrated in 
mitochondria exposed to CR in rat livers, hearts, and brains (Gredilla et al., 2001; 
Lambert and Merry, 2004; Sanz et al., 2005; Maalouf, Rho, and Mattson, 2009). 
Complex I was isolated by observing mitochondrial hydrogen peroxide production 
using different substrates. While mitochondria in CR animals produced less 
hydrogen peroxide than controls when given pyruvate and malate, no differences 
were observed when supplemented with succinate and rotenone. This indicates 
Complex I as the key site for CR's reduction in ROS production, as 
pyruvate/malate electrons flow through both complexes I and III, while with 
succinate/rotenone, electron flow through complex I is blocked by rotenone 
(Sanz et al., 2005). Moreover, this reduction in ROS is intricately tied to 
metabolic rate, as insulin treatment of CR animals can completely reverse these 
effects (Lambert and Merry, 2004). 
Calorie restriction's effects at the mitochondria are multiple and 
complicated. CR has also been tied to uncoupling proteins, which have been 
suggested to underly its attenuation of ROS production (Guarente and Koubova, 
2003; Maalouf, Rho, and Mattson, 2009). Uncoupling proteins allow the leakage 
of protons across the mitochondrial inner membrane, decreasing the driving force 
for ATP synthesis and ROS production. In fact, enhanced uncoupling activity has 
been associated with longevity (Conti et al., 2006; Maalouf, Rho, and Mattson, 
2009). Mice overexpressing the uncoupling protein UCP2 in hypocretin neurons 
regulating temperature enjoyed a 12-20% increase in median lifespan, better 
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energy efficiency, and, somewhat unexpectedly, a fall in core body temperature. 
While uncoupling proteins dissipate the proton gradient as heat, the limitation of 
heat production to the hypothalamus seems to have resulted in compensatory 
mechanisms that lowered core body temperature (Conti et al., 2006). Given this 
weakened proton gradient and the reduction in caloric intake, it’s surprising that 
CR animals would enjoy better (or equivalent) energy efficiencies than control 
animals. The answer to this paradox may be explained by CR's upregulation of 
mitochondrial biogenesis. While each individual mitochondria produces less ROS 
and less ATP, by having more mitochondria per cell, the cell's energy needs can 
still be met (Maalouf, Rho, and Mattson, 2009). However, if total ROS production 
per cell is also to decrease under CR, the marginal increase in ROS from an 
additional mitochondrion must be outweighed by the increase in ATP production. 
In fact, a fall in core body temperature is observed with CR animals in the 
long run, and this lower body temperature has also been suggested as a key to 
its anti-aging effects. While uncoupling proteins tend to produce heat and 
increase body temperature, CR animals consistently have lower core 
temperatures than their ad libitum counterparts, reflecting reduced energy 
expenditure (Lane et al., 1996). This effect has also been seen in humans, and a 
longitudinal study of aged men showed that those with lower body temperatures 
live longer than their counterparts (Soare et al., 2011). Given the uncertainty in 
long-term metabolic rates, the exact source of the temperature decrease is 
	  	   14 
unknown, and some have even proposed a reduction in uncoupling proteins to 
explain this effect (Guarente and Koubova, 2003). 
The exact mechanisms by which CR reduces ROS production is still not 
clear, but it clearly has significant effects at the mitochondria, which are known to 
accumulate damage with age (Guarente, 2008). It may be that having more 
functional mitochondria available could protect cells from death by buffering them 
energetically in the case of insults; what would have normally killed a cell now 
only weakens it (Guarente, 2008). 
However, much of the damage to proteins does not come in the form of 
oxidation, but glycation. Advanced glycation end products (AGE) are proteins 
that have glucose or other sugars covalently attached to them. Not only does 
AGE increase with age, but they have been implicated as a factor in certain age-
related pathologies. Calorie restriction reduces levels of AGE in serum, likely 
partially due to its reduction in glucose and insulin levels, as a lower blood 
glucose would reduce the driving force for protein glycation (Koubova and 
Guarente, 2003). In addition to inhibiting the function of the glycated protein, 
AGE have many downstream effects. For one, they are implicated in microglial 
activation and inflammatory damage through its receptor RAGE (Shapiro et al., 
2010).  AGE are also closely linked to S100b expression and secretion. S100b 
secreted by astrocytes can activate microglia through two different pathways, 
one of which is mediated by its binding to RAGE. More specifically, S100b 
binding to RAGE activates the NF-κB pathway in microglia, which can lead to 
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increased levels of the pro-inflammatory cytokines it controls, such as IL-1, IL-6, 
and TNF-α (Shapiro et al., 2010).  
While oxidative damage is evidently reduced by CR, it may not be the key 
to its neuroprotective effects. Much of the damage in brain injuries results not 
from the insult itself, but subsequent inflammatory damage. While this 
inflammation was once brushed aside and described by the catch-all “reactive 
gliosis,” it is now considered a major factor in the progression of 
neurodegenerative diseases (Zipp and Atkas, 2006).  
Calorie restriction has been seen to decrease the levels of inflammatory 
cytokines and markers in a number of experiments and animal models, and 
curbing excess inflammation in the brain could be the reason for its 
neuroprotective effects (Chung et al., 2002; Wilette et al., 2010). In particular, 
production of major inflammatory cytokines IL-6, IL-1β, and TNF-α are reduced in 
CR animals. CR reduces the levels of inflammatory transcription factor NF-κB via 
its antioxidant effect, and may be the reason for reduced levels of the 
aforementioned cytokines, all of whose promoters have redox-sensitive NF-κB 
binding sites and all of which have also been seen to increase with aging in 
various studies. At the same time, however, CR has been shown to increase 
phagocytic activity in alveolar macrophages and resistance to gram-positive 
bacteria while still reducing TNF-α and IL-6 levels (Chung et al., 2002). This 
moderation of inflammatory response (and not severe inhibition) is conducive to 
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allowing appropriate CNS responses to insult without potential damage 
associated with excess activation of inflammatory pathways. 
Hormesis has been suggested as a potential mechanism for calorie 
restriction's neuroprotective effects (Ingram et al., 2006). According to the 
hypothesis, CR subjects neurons and glia to low levels of stress, resulting in an 
upregulation in the expression of heat shock proteins, growth factors, energy-
regulating proteins, and other protective cellular mechanisms. However, the CR 
is not itself severe enough of a stressor to cause damage itself.  Neurons would 
become adapted to better protect against stressors like ROS and more likely to 
survive the wear and tear that accompanies decades of respiration (Mattson, 
2000; Maalouf, Rho, and Mattson, 2009). 
The neuroprotective effects of calorie restriction have been widely and well 
documented. CR's mechanisms seem to be wide-ranging, as neuronal resistance 
to a variety of stressors and toxins have been shown to increase in CR animals. 
Dopaminergic neurons are less vulnerable to MPTP toxicity, and hippocampal 
neurons are less susceptible to kainate-induced degeneration (Mattson, 2000). 
CR has been shown to ameliorate the damage or markers of stroke, ischemia, 
reperfusion, Alzheimer's, Parkinson's, and Huntington's, among others (Mattson, 
2000; Chung et al., 2002). ALS mouse models using a SOD mutation, however, 
did not see any effect, indicating the importance of oxidative stress in mediating 
CR's effects (Mattson, 2000). 
Some of its ameliorative properties may derive from its neurotrophic 
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effects. CR causes an increase in rat and mouse expression of brain-derived 
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and glial-derived neurotrophic 
factor (GDNF), all of which have neuroprotective effects. Higher levels of BDNF 
could promote plasticity and learning, as well as suppressing oxidative stress and 
stabilizing calcium homeostasis. Moreover, BDNF seems to mediate some of 
CR's protection against excitotoxic injury. When rats were pre-treated with a 
blocking anti-BDNF antibody that blocks its effect, the protective effect against 
excitotoxic injury was attenuated (Mattson, 2000; Maalouf, Rho, and Mattson, 
2009).  
These neuroprotective effects of CR have also been seen functionally, with 
calorie-restricted mice and rhesus monkeys exhibiting better learning and motor 
performances than controls (Ingram et al., 1987; Kastman et al., 2010). CR has 
also been seen to ameliorate age-related decline in white matter integrity in 
certain areas of the brain, as represented by FA values from MRI images 
(Bendlin et al., 2011). However, the literature on calorie restriction in non-human 
primates and the aging brain is scarce. There are only two ongoing CR studies 
using NHPs, both initiated in the 1980s (Kemnitz, 2011). 
Long-term calorie restriction studies on non-human primates began in 
1989 at the NIA and 1989 at the WNPRC (McDonald and Ramsey, 2010).  As 
data is released from these two studies, CR can be more carefully studied in a 
more appropriate animal model. In fact, recent results published from these two 
studies have yielded contradictory findings  (Colman et al., 2009; Mattison et al., 
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2012). While data from the WNPRC has revealed longevity benefits in from a CR 
diet,  NIA  data  has shown no significant life-extending effect. However, both 
studies found differences in disease incidences between CR and control animals, 
particularly with respect to obesity.  
The discrepancies in results may due to the fact that the two studies use 
significantly different diet regimens and levels of medical care. In the WNPRC 
study, animals who suffer from chronic disease are given clinical care similar to 
humans, with every effort made to relieve pain and discomfort while prolonging 
life. On the other hand, NIA monkeys with chronic diseases are euthanized so as 
not to skew data, as their diseased state makes them ill-suited for statistical 
comparison to controls (Kemnitz, 2011).  
Furthermore, WNPRC monkeys were fed a diet consisting of purified 
ingredients, whereas the NIA macaques' diets had a natural ingredient base. In 
other words, macronutrients were extracted, purified, and mixed in appropriate 
ratios and then fortified with necessary micronutrients in the WNPRC study, while 
the NIA study used ground-up natural ingredients in the ratios needed to provide 
the necessary macronutrient balance and micronutrient content. Moreover, while 
macronutrient (carbohydrates, fats, proteins) proportions were comparable, the 
source of macronutrients differed significantly. For instance, nearly 30% of the 
WNPRC diet was sucrose (about half of carbohydrate intake), as opposed to only 
3.9% of the NIA diet. Given the different ingredient bases and high sucrose 
content of the WNPRC diet, it is possible that control animals in the WNPRC 
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group were fed a relatively unhealthy diet that lends itself to obesity and other 
diseases more so than the NIA control diet. In that case, improvements in CR 
animals cannot be attributed to calorie restriction alone.   
The current study uses brains from rhesus monkeys in the NIA study, 
which has not yet shown an increase in lifespan or decrease in morbidity for 
aging-related diseases, although the NIA study is still ongoing (Mattison et al., 
2012). 
 
AIMS 
 
Given that calorie restriction seems to have general salutary effects, we 
wanted to investigate its impact on the aging brain, and if CR can indeed 
ameliorate age-related degeneration in the white matter. As no prior 
immunohistochemical studies exist on white matter in CR animals as compared 
to control, we expected to gain valuable information from whatever the results 
may be. Moreover, if CR animals can indeed be shown to have statistically 
significant differences in inflammation or oxidative stress in aging-susceptible 
white matter areas versus control, it can help us uncover the underlying 
degenerative changes in aging. It was hypothesized that there would be less of 
the inflammatory marker S100b in aging-susceptible white matter areas in CR 
brains, which would imply that calorie restriction reduces inflammation in the 
brain, as well as providing evidence that age-related white matter degeneration is 
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at least partially a function of inflammatory insults to the white matter. Further 
studies beyond this thesis is required and will continue using supplemental MRI 
data and perhaps other robust immunohistochemical markers (particularly 4-
HNE, an oxidative stress marker with which we have not yet been able to 
establish consistent staining). 
 
Non-human primates 
 
For this study, rhesus monkeys were used as an animal model for the aging 
human brain. The use of NHP was necessary, as they are the most similar 
animals to humans, especially with regards to their central nervous system. 
While CR has been shown to extend life in smaller mammals, these effects may 
not translate to larger animals like humans. Therefore, it becomes necessary to 
use NHPs to investigate any potential salutary effects on the brain. Not only are 
their brains very similar to ours, but rhesus monkeys also undergo similar aging 
processes. They do not, however, suffer from Alzheimer's disease, which makes 
them especially suitable for studying normal aging, as they are unlikely to suffer 
from a neurodegenerative disease that can cause brain damage on a scale much 
greater than the normal aging process (Levin and Buccafusco, 2006). Moreover, 
they enjoy long lives like humans, but on a shorter time scale (about 1:3), 
allowing for translatable longevity studies on a timescale that is still conducive to 
research (Tigges et al., 1998). 
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METHODS 
 
Chinese rhesus monkeys from the NIA were sustained on a natural 
ingredient diet composed of 56.9% carbohydrates, 17.3% proteins, and 5% fats 
(Mattison et al., 2012).  Calorie restricted monkeys were fed 70% of ad libitum 
diets, introduced over a 3 month period, with 10% and 20% reductions in food 
intake in the first two months (Lane et al., 1996; Mattison et al., 2012). Calorie 
restriction was introduced at either juvenile age (3-5 years) or adulthood (16-23 
years). Animals were maintained with modern husbandry practices and 
euthanized in cases where chronic disease existed (Kemnitz, 2011; Mattison et 
al., 2012). Brains were then extracted and preserved in 4% formaldehyde 
solution for an average of approximately 6 years before being received at Boston 
University for study. Upon arrival, hemispheres were photographed and then 
transfered into a 10% glycerol solution in 0.1 M phosphate buffered saline (PBS) 
for one week at 4°C  before being transferred into 20% glycerol in 0.1 M PBS for 
cryoprotection. Hemispheres were then flash-frozen in -70° C 2-methyl butane 
and stored in -80° C freezers until ready for cutting. Frozen hemispheres were 
cut in 30 micron sections on a sliding freezing microtome and stored in 15% 
glycerol in 0.1 M PBS for one week at 4° C before being frozen overnight in a -
20° C freezer and finally transferred after 24 hours into a -80° C freezer. Sections 
used for experiments were thawed in a room-temperature water bath and 
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thoroughly washed with 0.1 M PBS before any immunohistochemistry 
proceeded. 
IHC protocol 
 
As the brains used in this study were fixed in formaldehyde for a number 
of years, target proteins were cross-linked, covering up antigenic sites. In order 
to remove these cross-links to allow antibody binding, antigen retrieval was 
performed on all sections. Following a PBS wash, sections were washed with 
citrate buffer (10 mM trisodium citrate dehydrate, pH balanced to 6 HCl) for one 
hour, during which time two rounds of microwaving were perfomed at a power of 
550 Watts at 50° C for 5 minutes in a Pelco Biowave, spaced 30 minutes apart 
(Ferris et al., 2009). Following more PBS washes, endogenous peroxidases were 
quenched with 5% hydrogen peroxide in 0.1 M PBS for 45 minutes and washed 
again. Sections were blocked and permeabilized with a solution containing 0.1 M 
PBS, 10% Normal Goat Serum (NGS), and 0.4% Triton-X for 2 hours (during 
which two 3 minute microwaves were performed at 150 W and 80° C). Sections 
were then incubated in primary mouse anti-S100b antibody at 1:1000 
concentration for two hours at room temperature (with two 5 minute microwaves 
at 150 W and 80° C) before being incubated at 4° C overnight. 
24 hours later, sections were washed of antibody and then incubated in 
1:600 Goat anti-mouse secondary antibody solution, with two more microwaving 
sessions (3 minutes, 150 W, 80° C). Following a PBS wash, sections were 
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placed for an hour in ABC solution containing an avidin-biotinylated peroxidase 
complex. Avidin binds the biotinylated secondary antibody, attaching the 
biotinylated peroxidase for the staining reaction. After ABC solution has been 
thoroughly washed off, sections were stained in 3,3'-Diaminobenzidine solution 
for two minutes and washed again in buffer before being mounted on glass 
slides. Tissue was allowed to dry for at least one night before being further 
dehydrated in a series of alcohol gradients, cleared with xylene, and coverslipped 
in with Permount.  
Three regions of interest were then delineated on the stereoinvestigator: 
the corpus callosum, cingulum, and an area of visual cortex (V1) in the occipital 
lobe, each at the same depth in each section. The corpus callosum was 
delineated by the hemispheric cut, ventricle, cingulate cortex, and a line parallel 
to the cut extending from the sulcus between the cingulate and superior frontal 
gyrus to the border of the corpus callosum and striatum. This line also served as 
the lateral border for the cingulate white matter. A section of V1 (primary visual 
cortex) bordering the calcarine fissure was delineated using two lines extending 
from the calcarine sulcus and its gyrus. The stereoinvestigator was then used to 
acquire images at 20x with a random sampling of each area, which were then 
used to determine S100b expression without bias (Fleming et al., 2011). Pictures 
measured 840 microns by 630.5 microns. Images were processed in ImageJ, 
where they were converted to black and white and optimized for contrast. 
Stained cells were then counted on the black and white version, with both images 
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available for comparison (color and black and white). Approximately 7-10 images 
were counted per ROI per section, with three sections for each animal. Counts 
per unit area were then averaged for each ROI in each section. Three ROI 
averages were then themselves averaged to produce the animal's average 
density of labeled cells.   
Statistical analysis was used to asses group differences in S100b 
expression. Outliers were determined by Grubbs' test and omitted. The 
hypothesis that calorie restricted animals would have less S100b labeling than 
control animals was tested using a two-tailed t-test. Moreover, Pearson's 
correlation was used to assess the relationship between age and S100b 
expression. All data is reported as means ± the standard error of the mean 
unless otherwise stated. 
 
RESULTS 
 Despite being stored in formaldehyde for a number of years, robust 
staining was achieved with S100b. The two antigen retrievals in citrate buffer 
allowed the reversal of protein cross-linking, and additional microwave sessions 
helped antibody penetration as well as speeding up the process of its binding. 
Staining can be seen in Figures 2-4. 
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FIGURE 2 
 
Example photograph of S100b staining in the cingulum of a calorie-restricted 
rhesus monkey. Astrocytes predominate, although labeled microglia can also be 
observed. 
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FIGURE 3 
 
Example photograph of S100b staining in the corpus callosum of a calorie-
restricted rhesus monkey. White matter tracts projecting to and from the midline 
are easily visible. Most labeled objects are astrocytes, with some microglia 
staining. 
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FIGURE 4 
 
 
Example image of a black and white photograph of the corpus callosum in a 
control rhesus monkey. Labeled astrocytes and microglia are easily visible 
against the white matter background. Contrast has been enhanced to optimize 
counting, and labeled cell bodies are counted with a blue marker in ImageJ. 
 
7-10 images per region per mounted section of rhesus monkey brain were 
analyzed to determine S100b expression. Each animal had 3 sections analyzed, 
for a total of 21-30 images per region per animal. Average S100b expression 
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levels in the cingulum and corpus callosum did not differ significantly between 
calorie-restricted and control animals, which can be seen in Tables 1 and 2, as 
well as Figure 5.  Comparing S100b expression in the cingulum between the two 
groups using a student’s two-tailed t-test returned [t(6) = 0.36, p = 0.73] as seen 
in Table 4. Similarly, in the corpus callosum, a two-tailed t-test [t(5) = 0.20, p = 
0.85] indicated no statistically significant difference in average S100b levels 
between the two groups (Table 4). 6 animals also had one section of the primary 
visual area (V1) gray matter in the occipital lobe counted as an internal control 
(Table 3). After removing an outlier detected by Grubb's test (likely due to poor 
staining, as that animal also had depressed S100b counts in the cingulum and 
corpus callosum), the average S100b expression in the two groups was 
compared using a t-test as seen in Table 4. There was no statistically significant 
difference between the groups [t(6) = 0.01, p = 0.99]. S100b expression 
correlated with age (0.26) in V1 when all non-outliers were compared, an 
expected result if S100b correlates with inflammation levels. 
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Figure 5 
 
Bar graph of S100b expression differences between CR and control animals in 
the cingulum, corpus callosum, and primary visual cortex. The Y axis represents 
S100b-labeled cells per 840 x 630.5 micron image. 
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Average S100b expression levels in the cingulum bundle of 4 calorie-restricted 
and 4 control animals. Values are expressed as labeled cells/picture (840 x 630.5 
microns) and is an average of 3 different sections from the same animal. [t(5) = 
0.20, p = 0.85]. 
 
Table 1 
Name Age Control 
S100b  
Calorie-
restricted 
S100b 
Age Name 
CR004 22 88.47 90.12 22 CR010 
CR012 27 96.33 88.83 25 CR011 
CR005 33 80.55 93.77 36 CR006 
CR009 39 77.33 87.76 37 CR007 
Average 30.25 85.67 ± 4.25 90.12 ± 1.31 30  
Correlation 
(p) 
 -0.77 (0.23) 0.2 (0.80)   
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† Outlier as determined by Grubb's test. 
‡ Calculated without outlier 
Average S100b expression levels in the corpus callosum of 4 calorie-restricted 
and 4 control animals. Values are expressed as labeled cells/picture (840 x 630.5 
microns) and is an average of 3 different sections from the same animal. [t(6) = 
0.36, p = 0.73]. 
 
Table 2 
 
Name Age Control 
S100b 
Calorie-
restricted 
S100b 
Age Name 
CR004 22 49.07 52.2 22 CR010 
CR012 27 47.71 49.1 25 CR011 
CR005 33 29.15†  48.98 36 CR006 
CR009 39 48.04 58.67 37 CR007 
Average 30.25 48.27‡ ± 0.41 52.24 ± 2.27 30  
Correlation 
(p) 
 -0.55 (0.63) 0.40 (0.60)   
 
 
	  	   32 
 
 
† Outlier as determined by Grubb's test. 
‡ Calculated without outlier 
Average S100b expression levels in the corpus callosum of 4 calorie-restricted 
and 4 control animals. Values are expressed as labeled cells/picture (840 x 630.5 
microns) and is an average of 3 different sections from the same animal. [t(6) = 
0.01, p = 0.99]. 
 
Table 3 
 
Name Age Control 
S100b  
Calorie-
restricted 
S100b 
Age Name 
CR012 27 119.75 103 22 CR010 
CR005 33 35.86†  105 25 CR011 
CR009 39 122.14  97 36 CR006 
Average 33‡ 120.95‡±1.20 101.67±2.40 27.67  
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Average values for CR and control animals in the cingulum, corpus callosum, 
and visual cortex (V1). No significant differences were observed. 
 
Table 4 
 
Region Control CR T-value P-value 
Cingulum 85.67±4.25 90.12±1.31 0.36 0.73 
Corpus Callosum 48.27±0.41 52.24±2.27 0.20 0.85 
V1 Gray Matter 120.95±1.12 101.67±2.40 0.01 0.99 
 
A difference between the two groups in the direction of correlation of 
inflammation and aging was seen in the corpus callosum and cingulum as well. 
In the cingulum, S100b expression negatively correlated with age (-0.77, p=0.23 
for a two-tailed hypothesis) in control animals and positively (0.20, p=.80) in CR 
animals (Table 1). Likewise, in the corpus callosum correlation with age was 
negative (-0.55, p=.63) for controls and positive (0.40, p=.60) for CR animals 
(Table 2). This lack of trend is unsurprising, as this is an aged cohort of animals 
from the NIA. The youngest animals were 22 years of age, which correlates to 
approximately 66 human years (Tigges et al., 1988), with an average age of 
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approximately 30 years. Given the advanced age of all of the subjects, it is 
difficult to observe any trends with age. 
Differences between average S100b levels were also insignificant. It may 
be that our sample size is simply too small to establish a significant difference in 
means. In the corpus callosum, the control group consisted of 4 animals, aged 
22-39 with a mean of 48.27 ± 0.41. The calorie-restricted group also consisted of 
4 animals, aged 22-37 with a mean of 52.24 ± 2.27. In the cingulum, controls 
(mean 85.67 ± 4.25) also had less S100b expression than CR animals (mean 
90.12 ± 1.31), albeit without significance. A graphical representation of the results 
can be seen in Figure 5. 
The lack of significance could be attributed to a number of factors. For 
one, our sample size is small. With only 8 animals, potential idiosyncratic 
differences between the animals are magnified. The loss of an animal due to an 
outlier (CR005 in the cingulum and Area 17 Gray Matter) exacerbate this 
problem. Some error may possibly be ascribed to problems in counting. 
Moreover, due to slight variations in staining intensity, the number of counted 
objects could vary from section to section, as intensity minimums were not 
constant from section to section. Due to time constraints, counts were acquired 
by taking a random sample of photographs of the ROI using the 
stereoinvestigator, and labeled cells were counted in each image using ImageJ. 
Static images make counting more difficult, especially in cases when cells aren't 
perfectly in the plane of view. Moreover, counting large images allows for more 
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error, as a few cells among possibly over 100 could easily be missed. On the 
other hand, using the stereoinvestigator with a limited 100 micron by 100 micron 
counting frame can ensure that every labeled cell in the counting frame is 
counted. It also allows the use of focus to better decide in cases where labeling 
may not be clear. 
Furthermore, all labeled cells were counted in this experiment due to time 
limitations. Upon recounting, cell types, specifically microglia and astrocytes, will 
be counted separately. Morphologically different types of microglia and 
astrocytes may also be noted.  While astrocytes showed the most intense 
staining, microglia were numerous, and could be seen in both round and ramified 
phenotypes, indicating different states of activation that could be significant in 
measuring levels of inflammation. These factors could all contribute to increasing 
variation and error impacting the significance of our findings. 
 
DISCUSSION 
 
 In this first screen of valuable ex vivo CR brains, no difference was found 
in S100b expression levels from control. While there have been previous MRI 
studies investigating differences between CR brains and controls in aged rhesus 
monkeys, no immunohistochemical studies of aged CR rhesus brains have been 
published to this date. This study can therefore be thought of as a first screen of 
CR brains to observe any major differences. S100b expression between CR and 
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control animals was analyzed in three regions: the cingulum, the corpus 
callosum, and primary visual cortex as an internal control. Further regions will be 
studied in the future, and more specific counting will be done as well (e.g. 
activated and non-activated microglia). 
The corpus callosum is the major connection between the two 
hemispheres of the brain. It is likely the main pathway for interhemispheric 
communication and is susceptible to age-related damage and neurodegeneration 
(Frederiksen and Waldemar, 2012). Meanwhile, the cingulum is important in 
intrahemispheric cortical connections and is implicated in a number of functions, 
including working memory and attention (Catheline et al., 2010; Sasson et al., 
2013). Moreover, low FA values in the cingulum have been correlated to 
functional deficits in Alzheimer's disease and cases of mild cognitive impairment 
(Zhang et al., 2007). MRI studies have shown decreases in FA in both the 
cingulum and corpus callosum with aging and cognitive decline (Zhang et al., 
2007; Sasson et al., 2013). Low FA values are thought to be indicative of 
damage to the white matter, as they imply water molecules are less restricted in 
traveling down axons. They have also been correlated with various functional 
cognitive deficits (Sasson et al., 2013). Therefore the corpus callosum and 
cingulum are good areas to investigate age-related changes in white matter. 
We investigated S100b expression differences in an aged cohort of rhesus 
monkeys fed control and CR diets. Given the advanced age (22-39 years, 
approximately equivalent to 66-117 human years) of the animals, age-related 
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pathologies can be expected to be present in the white matter, as established by 
Peters (2002). Inflammation has also been observed to increase with age in a 
number of animal models (Chung et al., 2002; Joseph et al., 2005). Moreover, 
measures of inflammation increase with age in the corpus callosum in humans, 
and low FA measures and inflammatory measures in the CC are positively 
correlated with cognitive deficits (Arfanakis et al., 2013). On the other hand, 
calorie restriction has been shown to reduce the levels of aging-associated 
inflammatory markers and resulting FA decreases associated with them (Willette 
et al., 2010). S100b expression has been linked to various forms of neurological 
insults and particularly neuroinflammation (Shapiro et al., 2010). If S100b 
expression levels are indeed a good marker of inflammation, we should therefore 
expect to find lower S100b expression levels in CR animals in both the corpus 
callosum and cingulum.  
Conversely, the average S100b levels (as measured by labeled astrocytes 
and microglia) were on average less in the control groups than CR. However, 
none of these results were statistically significant (p>0.1). These results are in 
contrast to the hypothesis that CR would reduce levels of S100b in the cingulum 
and corpus callosum. Interestingly, S100b expression in our internal control, the 
gray matter of the primary visual cortex, was lower in CR animals compared to  
controls. This difference was insignificant (p=0.99), but further analysis of gray 
matter may in fact reveal significant differences. 
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The methods by which CR may exert its effects are not clear, but it is fairly 
certain that they have less systemic inflammation than their non-restricted 
counterparts. In numerous animal models and using multiple markers, CR 
animals have consistently had lower levels of inflammatory cytokines and 
markers in serum (Lane, Ingram, and Roth, 1999; Chung et al., 2002; Willette et 
al., 2010). Just as calorie restriction may be acting a variety of ways to achieve 
its life-extending effects, the causes of decreased inflammation are likely multiple 
(Chung et al., 2002). In any case, if S100b expression is correlated with the 
general or peripheral inflammatory state of an animal, then calorie restriction 
should be expected to decrease S100b expression. 
While other pro-inflammatory markers are decreased in CR animals, 
perhaps S100b is in fact upregulated. Despite its anti-inflammatory effects, CR 
has been shown to increase phagocytosis and bacterial resistance (Chung et al., 
2002). It could be that CR has differential effects on different inflammatory 
proteins. Or, it could be that the range of S100b expression observed is not in a 
pathological range. Low levels of secreted S100b (nanomolar range) are 
neurotrophic. It is only at much higher, micromolar concentrations that secreted 
S100b mediates inflammatory processes (Sorci et al., 2010). At the level of 
S100b expression recorded in the present study, higher S100b expression could 
reflect neuroprotective functions. In the same vein, if total S100b expression is 
interpreted as representing immune function, higher levels of S100b would 
indicate a more robust immune response in CR animals compared to controls. 
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Without knowing whether the levels of S100b expression measured in the corpus 
callosum and cingulum are at pathological or physiological levels, it is difficult to 
interpret the results. 
The biggest confounding factor is the fact that all S100b-labeled cells were 
counted in this study due to time constraints. While astrocytes were numerous in 
every section, anecdotally, microglia labeling varied significantly from image to 
image. Taking into consideration different activation states of microglia from 
morphology may also reveal significant differences between CR and control 
animals. 
However, the higher average levels of S100b in CR animals are not 
significant. The parsimonious hypothesis would simply be that calorie restriction 
has no effect on S100b expression in these areas. Indeed, while CR has been 
found to have an effect in preventing age-related FA decline in varied regions, 
the cingulum and corpus callosum were not among them (Bendlin et al., 2011). 
Despite all its positive effects in lower animals, the effectiveness of CR in 
primates is still under debate. This study uses brains from the NIA, which has not 
found any increase in lifespan or fall in mortality when compared to controls 
(Mattison et al., 2012). When executed properly, CR may have little effect on 
primate lifespan and major inflammatory markers. Indeed, the correlation 
between FA values and circulating levels of the pro-inflammatory cytokine IL-6 
was established using WNPRC monkeys, as have a number of other positive 
findings in NHPs. 
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The most likely explanation for our results, however, is a lack of significant 
difference owing to small sample size and potential errors in counting. As 
mentioned previously, time constraints dictated a certain counting methodology 
that lends itself more easily to errors than the traditional method of unbiased 
stereology. With more animals to increase statistical power, coupled with 
unbiased stereology, we expect to find significant decreases in S100b expression 
in CR animals, as well as a significant correlation of expression with age. 
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